Correlation Between Crinetics Pharmaceuticals and Cytokinetics
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Cytokinetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Cytokinetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Cytokinetics, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Cytokinetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Cytokinetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Cytokinetics.
Diversification Opportunities for Crinetics Pharmaceuticals and Cytokinetics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Crinetics and Cytokinetics is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Cytokinetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytokinetics and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Cytokinetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytokinetics has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Cytokinetics go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Cytokinetics
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to under-perform the Cytokinetics. In addition to that, Crinetics Pharmaceuticals is 1.35 times more volatile than Cytokinetics. It trades about -0.14 of its total potential returns per unit of risk. Cytokinetics is currently generating about -0.01 per unit of volatility. If you would invest 5,182 in Cytokinetics on November 1, 2024 and sell it today you would lose (185.00) from holding Cytokinetics or give up 3.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Cytokinetics
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Cytokinetics |
Crinetics Pharmaceuticals and Cytokinetics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Cytokinetics
The main advantage of trading using opposite Crinetics Pharmaceuticals and Cytokinetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Cytokinetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will offset losses from the drop in Cytokinetics' long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
| Cytokinetics vs. Edgewise Therapeutics | Cytokinetics vs. Dyne Therapeutics | Cytokinetics vs. Stoke Therapeutics | Cytokinetics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |